Droxicam
Droxicam
 |
 |
| Systematic (IUPAC) name |
|---|
|
2H,5H-1,3-Oxazino(5,6-c)(1,2)benzothiazine-2,4(3H)-dione, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide |
| Clinical data |
|---|
| Identifiers |
|---|
|
M01AC04 |
|---|
| PubChem |
CID 65679 |
|---|
| ChemSpider |
59108  N |
|---|
| UNII |
F24ADO1E2D  Y |
|---|
| KEGG |
D07267 Y |
|---|
| ChEBI |
CHEBI:76133 N |
|---|
| Chemical data |
|---|
| Formula |
C16H11N3O5S |
|---|
|
357.34064 g/mol |
|---|
SMILES
- CN1c2c(oc(=O)n(c2=O)c3ccccn3)-c4ccccc4S1(=O)=O
|
InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3
N
Key:OEHFRZLKGRKFAS-UHFFFAOYSA-N
N
|
| N (what is this?) (verify) |
|---|
Droxicam is a non-steroidal anti-inflammatory drug of the oxicam class. A prodrug of piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) |
|---|
| Pyrazolones /
Pyrazolidines | |
|---|
| | Salicylates | |
|---|
| Acetic acid derivatives
and related substances | |
|---|
| | Oxicams | |
|---|
| Propionic acid derivatives
(profens) | |
|---|
| N-Arylanthranilic acids
(fenamates) | |
|---|
| | Coxibs | |
|---|
| | Other | |
|---|
| | | |
|---|
| | Description |
- Anatomy
- head
- neck
- arms
- chest and back
- diaphragm
- abdomen
- genital area
- legs
- Muscle tissue
- Physiology
|
|---|
| | Disease |
- Myopathy
- Soft tissue
- Connective tissue
- Congenital
- abdomen
- muscular dystrophy
- Neoplasms and cancer
- Injury
- Symptoms and signs
|
|---|
| | Treatment |
- Procedures
- Drugs
- anti-inflammatory
- muscle relaxants
|
|---|
|
|